Post-approval translational research itself has diverse ethics.
Mukherjee
Joia
J
Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. jmukherjee@pih.org
D000890:Anti-Infective Agents / Q000627:therapeutic use; D017327:Clinical Trials, Phase IV as Topic / Q000941:ethics*; D016265:Conflict of Interest; D017277:Drug Approval; D004345:Drug Industry / Q000941:ethics; D024841:Fluoroquinolones / Q000627:therapeutic use; D006801:Humans; D007258:Informed Consent / Q000941:ethics; D008581:Meningitis / Q000188:drug therapy; D009549:Nigeria; D011203:Poverty; D012109:Research Support as Topic / Q000941:ethics; D036302:Therapeutic Human Experimentation / Q000941:ethics; D057170:Translational Research, Biomedical / Q000941:ethics*; D035862:Vulnerable Populations
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; C106856:alatrofloxacin